Study to Characterize the PK and Local Extent and Duration of Exposure From FX006 in Patients With OA of the Knee
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Neil Bodick, MD
Flexion Therapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Canoga Park, California, United States
- Facility name not stated
San Diego, California, United States
- Facility name not stated
Hialeah, Florida, United States
- Facility name not stated
Duncansville, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2015
- Primary completion
- 30 Sept 2016
- Completion
- 30 Sept 2016
- Last update posted
- 24 Jan 2024
- Registered enrollment
- 81
- Registry id
- NCT02637323
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.